High levels of debt obligations have led several biotechnology and pharmaceutical companies into financial distress, requiring them to file for bankruptcy and, in many cases, seek sales of their ...

The average American can expect to live about 77 years, according to the Centers for Disease Control and Prevention. Retro ...

Honda Motor Co. Chief Executive Toshihiro Mibe called the decisions “a switch in the planned course,” while stressing the ...

Home Depot doesn’t expect to raise prices because of tariffs, saying it has spent years diversifying the sources for the ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

Schrödinger is laying off 60 staffers, or about 7% of its workforce, in an effort to save cash and boost efficiency. | ...

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility Tuesday in Smithfield.